Antidiarrhoeal (Opioid Receptor Agonist — Peripheral)
Pregnancy: Caution — limited data; avoid in first trimester; use in later pregnancy only if clearly needed.
Loperamide Hydrochloride
Brand names: Imodium, Arret
Adult dose
Dose: Acute diarrhoea: initially 4mg, then 2mg after each loose stool. Chronic diarrhoea: 4–8mg/day in divided doses, adjusted to response.
Route: Oral (capsules, tablets, or liquid)
Frequency: After each loose stool (acute); regular divided doses (chronic)
Max: 16mg/day
For acute diarrhoea: do not use >48 hours without medical assessment. Do not use in bloody diarrhoea or suspected infectious colitis (bowel perforation risk from delayed transit). For ileostomy: highly effective for high-output stoma — doses up to 16mg/day used regularly.
Paediatric dose
Route: Oral
Frequency: After each loose stool or 2–4 times daily
Max: 2mg per dose
Licensed for acute diarrhoea ≥12 years only (MHRA restriction). Off-label (BNFC) for chronic diarrhoea: ≥4 years — 100–200 micrograms/kg (max 2mg) 2–4 times daily under specialist supervision only. Not for acute infectious diarrhoea in children. Source: BNF for Children 2024.
Dose adjustments
Renal
No dose adjustment required.
Hepatic
Use with caution in hepatic impairment — increased systemic exposure may cause CNS toxicity.
Clinical pearls
- Acts on enteric μ-opioid receptors — reduces gut motility and secretion without significant CNS penetration at therapeutic doses.
- MHRA 2018: loperamide misuse at high doses causes serious cardiac arrhythmias (QT prolongation, ventricular tachycardia). Never exceed 16mg/day.
- Ileostomy high-output: loperamide is highly effective — take 30 min before meals and at night. Doses up to 16mg/day routinely used in specialist settings.
- Do not use in antibiotic-associated or infective colitis — prolongs carrier state and may worsen outcomes.
Contraindications
- Acute bloody diarrhoea or dysentery
- Acute ulcerative colitis (risk of toxic megacolon)
- Antibiotic-associated colitis (Clostridioides difficile — do not use antimotility agents)
- Acute surgical abdomen
Side effects
- Constipation (most common — dose-dependent)
- Abdominal cramping, bloating
- Nausea
- Toxic megacolon (if used in active colitis — rare but life-threatening)
- CNS effects (dizziness, drowsiness) at high doses or in hepatic impairment
Interactions
- QT-prolonging drugs: loperamide at high doses may prolong QT (caution)
- P-glycoprotein inhibitors (quinidine, ritonavir): increase loperamide CNS penetration — CNS toxicity at standard doses
Monitoring
- Stool frequency and consistency
- Hydration status
- Signs of toxic megacolon (fever, abdominal distension)
Reference: BNFc; BNF 90; MHRA Drug Safety Update 2018 (Loperamide); SPC Imodium. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Morphine Milligram Equivalents (MME) Calculator · Pain / Opioids
- Opioid Conversion / Equianalgesic Guide · Pain Management
- Numeric Rating Scale (NRS) Pain Assessment and Management · Pain Management
- HINTS Plus (Central vs Peripheral Vertigo) · Vertigo / Dizziness
- Carpal Tunnel Syndrome-6 (CTS-6) Diagnostic Tool · Peripheral Nerve
- Peripheral Blood Stem Cell (PBSC) Collection Target Calculator · Stem Cell Transplant
Pathways
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021